In the BioHarmony Drug Report Database

"Preview" Icon

Milrinone

Primacor (milrinone) is a small molecule pharmaceutical. Milrinone was first approved as Primacor on 1987-12-31. It is used to treat heart failure in the USA. The pharmaceutical is active against cGMP-inhibited 3′,5′-cyclic phosphodiesterase A. In addition, it is known to target cGMP-specific 3′,5′-cyclic phosphodiesterase, cGMP-inhibited 3′,5′-cyclic phosphodiesterase B, cGMP-dependent 3′,5′-cyclic phosphodiesterase, and transthyretin.

 

Trade Name

 

Primacor
 

Common Name

 

milrinone
 

ChEMBL ID

 

CHEMBL189
 

Indication

 

heart failure
 

Drug Class

 

Cardiotonics (amrinone type)

Image (chem structure or protein)

Milrinone structure rendering